Literature DB >> 23403435

Successful management of voriconazole-associated hyponatremia with therapeutic drug monitoring.

Ren-ai Xu, Guan-yang Lin, Lu-feng Hu, Da-wei Shi, Xiao-lan Ye, Yun-jie Liu, Xiao-feng Pan, Chun-hong Zhang, Xiu-hua Zhang.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23403435      PMCID： PMC3632950          DOI： 10.1128/AAC.00146-13

Source DB:  PubMed          Journal:  Antimicrob Agents Chemother        ISSN： 0066-4804            Impact factor:   5.191


× No keyword cloud information.
  10 in total

1.  Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America.

Authors:  Thomas J Walsh; Elias J Anaissie; David W Denning; Raoul Herbrecht; Dimitrios P Kontoyiannis; Kieren A Marr; Vicki A Morrison; Brahm H Segal; William J Steinbach; David A Stevens; Jo-Anne van Burik; John R Wingard; Thomas F Patterson
Journal:  Clin Infect Dis       Date:  2008-02-01       Impact factor: 9.079

2.  Voriconazole-associated severe hyponatremia.

Authors:  Kye-Hyung Kim; Seunghwan Lee; Shinwon Lee; Na Ra Yun; Nam Joong Kim; Kyung-Sang Yu; In-Jin Jang; Wan Beom Park; Myoung-Don Oh
Journal:  Med Mycol       Date:  2011-06-15       Impact factor: 4.076

3.  Voriconazole-associated salt-losing nephropathy.

Authors:  Junya Teranishi; Katsuyuki Nagatoya; Tomoko Kakita; Yoko Yamauchi; Hirohisa Matsuda; Tatsuhiko Mori; Toru Inoue
Journal:  Clin Exp Nephrol       Date:  2010-06-22       Impact factor: 2.801

4.  The effect of therapeutic drug monitoring on safety and efficacy of voriconazole in invasive fungal infections: a randomized controlled trial.

Authors:  Wan Beom Park; Nak-Hyun Kim; Kye-Hyung Kim; Seung Hwan Lee; Won-Seok Nam; Seo Hyun Yoon; Kyoung-Ho Song; Pyoeng Gyun Choe; Nam Joong Kim; In-Jin Jang; Myoung-Don Oh; Kyung-Sang Yu
Journal:  Clin Infect Dis       Date:  2012-07-03       Impact factor: 9.079

5.  Effect of CYP2C19 polymorphism on the pharmacokinetics of voriconazole after single and multiple doses in healthy volunteers.

Authors:  SeungHwan Lee; Bo-Hyung Kim; Won-Seok Nam; Seo Hyun Yoon; Joo-Youn Cho; Sang-Goo Shin; In-Jin Jang; Kyung-Sang Yu
Journal:  J Clin Pharmacol       Date:  2012-02       Impact factor: 3.126

6.  Voriconazole-induced phototoxicity in children.

Authors:  Sara Bernhard; Kristin Kernland Lang; Roland A Ammann; Sonja Lüer; Kurt Leibundgut; Miriam Diepold; Christoph Aebi
Journal:  Pediatr Infect Dis J       Date:  2012-07       Impact factor: 2.129

7.  PCR identification system for the genus Aspergillus and three major pathogenic species: Aspergillus fumigatus, Aspergillus flavus and Aspergillus niger.

Authors:  Chise Sugita; Koichi Makimura; Katsuhisa Uchida; Hideyo Yamaguchi; Atsushi Nagai
Journal:  Med Mycol       Date:  2004-10       Impact factor: 4.076

8.  Voriconazole pharmacokinetics and pharmacodynamics in children.

Authors:  Michael Neely; Teresa Rushing; Andrea Kovacs; Roger Jelliffe; Jill Hoffman
Journal:  Clin Infect Dis       Date:  2010-01-01       Impact factor: 9.079

9.  Voriconazole therapeutic drug monitoring in patients with invasive mycoses improves efficacy and safety outcomes.

Authors:  Andres Pascual; Thierry Calandra; Saskia Bolay; Thierry Buclin; Jacques Bille; Oscar Marchetti
Journal:  Clin Infect Dis       Date:  2008-01-15       Impact factor: 9.079

10.  [Case of pulmonary aspergillosis associated with inappropriate antidiuretic hormone syndrome caused by voriconazole therapy].

Authors:  Kazutoshi Isobe; Sei Muraoka; Keishi Sugino; Yoko Yamazaki; Naoshi Kikuchi; Nobuyuki Hamanaka; Yujiro Takai; Kunihiko Shimizu; Kazuhiro Kimura; Naoki Hiroi; Kazutoshi Shibuya; Sakae Homma
Journal:  Nihon Kokyuki Gakkai Zasshi       Date:  2007-06
  10 in total
  1 in total

1.  The effects of cytochrome P450 2C19 polymorphism on the metabolism of voriconazole in vitro.

Authors:  Ren-Ai Xu; Er-Min Gu; Teng-Hui Liu; Qiu-Geng Ou-Yang; Guo-Xin Hu; Jian-Ping Cai
Journal:  Infect Drug Resist       Date:  2018-11-01       Impact factor: 4.003
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.